Drug intelligence / Profile preview

Ringerfundin

Development stage
Unknown
Lead developer
B. Braun
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Intravenous
01

Overview

Ringerfundin is a balanced full electrolyte solution used for intravenous infusion therapy. It has an isotonic electrolyte composition that closely resembles human plasma, making it suitable for fluid replacement and correction of acid-base imbalances. ## Composition and Properties Ringerfundin contains a balanced mixture of electrolytes including sodium, potassium, calcium, magnesium, and chloride, along with metabolizable anions[1][6]. Its composition is specifically designed to match the electrolyte profile of human plasma, which helps prevent electrolyte imbalances during fluid therapy[1][3]. Unlike some other crystalloid solutions, Ringerfundin's essential anions are metabolized in all organs and muscles with minimum oxygen consumption[1][7]. This metabolic stability is a key advantage, as it doesn't increase oxygen consumption or total energy requirements during administration[7]. ## Clinical Uses Ringerfundin is primarily indicated for: 1. Replacement of extracellular fluid losses in cases of isotonic dehydration[6][9] 2. Treatment of conditions with high acidity in the blood (acidosis) or where acidosis is imminent[5][6] 3. Fluid resuscitation in critical care settings, including septic shock[3] ## Clinical Benefits Research has demonstrated several advantages of Ringerfundin over other crystalloid solutions: - Better preservation of acid-base balance compared to alternatives like Ringer's lactate[3] - Prevention of dilutional acidosis during fluid therapy[6] - Being lactate-free, it allows lactate to be used as a marker of hypoxia[6] - Lower increase in serum chloride levels compared to Ringer's lactate[3] - Better clearance of lactate after administration[3] ## Administration Ringerfundin is administered intravenously, with dosage determined by the patient's clinical condition, weight, and laboratory parameters[5]. The solution should be used with caution in patients with certain conditions, including: - Increased blood volume - Severe heart or kidney disease - High potassium or calcium levels in the blood - Alkalosis (too much alkalinity in the blood)[5] Regular monitoring of fluid balance, electrolytes, and acid-base status is recommended during treatment to ensure proper balance is maintained[5].

Brand names
Ringerfundin
Other names
Ringer's acetate/malate solutionbalanced crystalloid solutionbalanced electrolyte solution
02

Targets

ClC (CLC chloride channel family)

Beyond the preview

Go deeper on Ringerfundin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ringerfundin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call